Profund Advisors LLC Myriad Genetics Inc Transaction History

Profund Advisors LLC

$2.59 Billion
Q3 2024

A detailed history of Profund Advisors LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Profund Advisors LLC holds 25,574 shares of MYGN stock, worth $350,619. This represents 0.03% of its overall portfolio holdings.

Number of Shares

25,574

Previous 21,140 20.97%

Holding current value

$350,619

Previous $517,000 35.2%

% of portfolio

0.03%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$23.97 - $28.6 $106,282 - $126,812	4,434 Added 20.97%	25,574 $699,000
Q2 2024 Aug 13, 2024	SELL	$17.98 - $25.47 $386,498 - $547,503	-21,496 Reduced 50.42%	21,140 $517,000
Q1 2024 May 08, 2024	BUY	$17.59 - $23.59 $177,694 - $238,306	10,102 Added 31.05%	42,636 $908,000
Q4 2023 Feb 14, 2024	SELL	$13.91 - $21.32 $87,702 - $134,422	-6,305 Reduced 16.23%	32,534 $622,000
Q3 2023 Nov 13, 2023	SELL	$15.99 - $23.22 $17,365 - $25,216	-1,086 Reduced 2.72%	38,839 $622,000
Q2 2023 Aug 10, 2023	BUY	$17.56 - $23.76 $61,951 - $83,825	3,528 Added 9.69%	39,925 $925,000
Q1 2023 May 11, 2023	BUY	$15.26 - $23.75 $555,418 - $864,428	36,397 New	36,397 $845,000
Q2 2022 Aug 01, 2022	SELL	$16.45 - $25.88 $144,118 - $226,734	-8,761 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$22.67 - $28.01 $15,234 - $18,822	672 Added 8.31%	8,761 $221,000
Q4 2021 Feb 08, 2022	SELL	$24.13 - $32.63 $6,249 - $8,451	-259 Reduced 3.1%	8,089 $223,000
Q3 2021 Nov 12, 2021	SELL	$29.97 - $36.66 $64,195 - $78,525	-2,142 Reduced 20.42%	8,348 $270,000
Q2 2021 Aug 12, 2021	BUY	$25.39 - $32.61 $23,308 - $29,935	918 Added 9.59%	10,490 $321,000
Q1 2021 May 14, 2021	BUY	$19.92 - $31.6 $190,674 - $302,475	9,572 New	9,572 $291,000
Q3 2020 Nov 13, 2020	SELL	$11.25 - $14.75 $246,296 - $322,921	-21,893 Closed	0 $0
Q2 2020 Aug 03, 2020	BUY	$10.69 - $16.49 $36,046 - $55,604	3,372 Added 18.21%	21,893 $248,000
Q1 2020 May 15, 2020	SELL	$9.78 - $29.53 $80,596 - $243,356	-8,241 Reduced 30.79%	18,521 $265,000
Q4 2019 Feb 18, 2020	BUY	$20.93 - $35.1 $9,899 - $16,602	473 Added 1.8%	26,762 $729,000
Q3 2019 Nov 12, 2019	BUY	$22.08 - $47.08 $35,460 - $75,610	1,606 Added 6.51%	26,289 $753,000
Q2 2019 Aug 13, 2019	SELL	$22.67 - $35.0 $61,889 - $95,550	-2,730 Reduced 9.96%	24,683 $686,000
Q1 2019 May 15, 2019	SELL	$26.93 - $34.7 $43,088 - $55,520	-1,600 Reduced 5.51%	27,413 $910,000
Q4 2018 Feb 14, 2019	SELL	$27.23 - $45.56 $234,504 - $392,362	-8,612 Reduced 22.89%	29,013 $843,000
Q3 2018 Nov 13, 2018	BUY	$37.57 - $50.34 $22,542 - $30,204	600 Added 1.62%	37,625 $1.73 Million
Q2 2018 Aug 13, 2018	BUY	$27.75 - $40.17 $2,969 - $4,298	107 Added 0.29%	37,025 $1.38 Million
Q1 2018 May 14, 2018	BUY	$28.83 - $41.01 $38,516 - $54,789	1,336 Added 3.75%	36,918 $1.09 Million
Q4 2017 Feb 14, 2018	SELL	$28.45 - $37.14 $128,081 - $167,204	-4,502 Reduced 11.23%	35,582 $1.22 Million
Q3 2017 Nov 13, 2017	BUY	$24.01 - $36.2 $97,384 - $146,827	4,056 Added 11.26%	40,084 $1.45 Million
Q2 2017 Aug 11, 2017	BUY	N/A	36,028	36,028 $931,000

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.5M

Call Options Held

100K

Put Options Held

34K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.11B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account

Profund Advisors LLC Myriad Genetics Inc Transaction History